Woodall, Maximillian N. J.
Cujba, Ana-Maria
Worlock, Kaylee B. http://orcid.org/0000-0002-5656-7634
Case, Katie-Marie
Masonou, Tereza
Yoshida, Masahiro http://orcid.org/0000-0002-3521-5322
Polanski, Krzysztof http://orcid.org/0000-0002-2586-9576
Huang, Ni
Lindeboom, Rik G. H. http://orcid.org/0000-0002-3660-504X
Mamanova, Lira
Bolt, Liam http://orcid.org/0000-0001-7293-0774
Richardson, Laura http://orcid.org/0000-0002-8075-3816
Cakir, Batuhan
Ellis, Samuel
Palor, Machaela http://orcid.org/0000-0003-4276-5346
Burgoyne, Thomas http://orcid.org/0000-0002-8428-720X
Pinto, Andreia http://orcid.org/0000-0002-0840-6844
Moulding, Dale http://orcid.org/0000-0002-1431-7047
McHugh, Timothy D. http://orcid.org/0000-0003-4658-8594
Saleh, Aarash
Kilich, Eliz http://orcid.org/0000-0003-0928-8293
Mehta, Puja http://orcid.org/0000-0001-9459-9306
O’Callaghan, Chris
Zhou, Jie
Barclay, Wendy http://orcid.org/0000-0002-6413-2454
DeCoppi, Paolo http://orcid.org/0000-0002-1659-0207
Butler, Colin R.
Cortina-Borja, Mario
Vinette, Heloise
Roy, Sunando
Breuer, Judith http://orcid.org/0000-0001-8246-0534
Chambers, Rachel C. http://orcid.org/0000-0003-1370-9417
Heywood, Wendy E.
Mills, Kevin
Hynds, Robert E.
Teichmann, Sarah A. http://orcid.org/0000-0002-6294-6366
Meyer, Kerstin B. http://orcid.org/0000-0001-5906-1498
Nikolić, Marko Z. http://orcid.org/0000-0001-6304-6848
Smith, Claire M. http://orcid.org/0000-0002-8913-0009
Article History
Received: 24 March 2023
Accepted: 4 March 2024
First Online: 15 April 2024
Competing interests
: In the past three years, S.A.T. has received remuneration for Scientific Advisory Board Membership from Sanofi, GlaxoSmithKline, Foresite Labs and Qiagen. S.A.T. is a co-founder and holds equity in Transition Bio and Ensocell. Starting 8 January 2024, S.A.T. has been a part-time employee of GlaxoSmithKline. All other authors declare no competing interests.